Parliament Workbench
Data: Motions & questions to 26 Nov 2026

Written Question · S7W-01925 · Session 7

For what reason the first meeting of the group established to consider the Scottish Health Technologies Group's recommendation that lidocai…

Answered Asked by Miles Briggs Con Lodged 22 Jul 2026

The question

To ask the Scottish Government for what reason the first meeting of the group established to consider the Scottish Health Technologies Group's recommendation that lidocaine infusions, lidocaine injections and radiofrequency treatment should continue for suitable chronic pain patients, scheduled for 29 April 2026, was cancelled, and whether it will publish details of the group's leadership, membership and remit.

The answer

Answered by Maree Todd on 13 Aug 2026 · 22 days after it was lodged, on time

The meeting planned to take place on the 29 April 2026, to discuss the formation of a short life working group to look at interventions for chronic pain, was cancelled to allow full consideration of the group’s remit, methodology, and membership.As this group has not been established, no information is available for publication concerning its leadership, membership, or remit.

In the Official Report

No contribution in the Official Report cites S7W-01925 by reference.